|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation | |||||
| Reduction in the carrying amount of right-of-use assets | |||||
| Share-based compensation | |||||
| Loss on disposal of property and equipment | |||||
| Allowance for doubtful accounts | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Deferred revenue | |||||
| Operating lease liability | |||||
| Net cash used in operating activities | |||||
| Investing activities: | |||||
| Purchase of property and equipment | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Exercise of common stock warrants | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Issuance costs of sale of common stock | |||||
| Net cash provided by financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosure of noncash investing and financing activities: | |||||
| Unpaid issuance costs of common stock | |||||
| Restricted stock units issued to settle management bonus obligations | |||||
Loading...